Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nazareth Eliana Ceschan"'
Publikováno v:
Fundamentals of Drug Delivery. :449-469
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a2148815edc8c19fdaf73f1e7f8446d
https://doi.org/10.1002/9781119769644.ch18
https://doi.org/10.1002/9781119769644.ch18
Autor:
Juan Manuel Figueroa, Melany Denise Rosas, Verónica Bucalá, María Eugenia Olivera, Nazareth Eliana Ceschan, Andrea V. Dugour, María Verónica Ramírez-Rigo
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Tuberculosis (TB) is a serious infectious disease that affects more than new 10 million patients each year. Many of these cases are resistant to first-line drugs so second-line ones, like fluoroquinolones, need to be incorporated into the therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c022aa82d2e69a965592f679ba8fc5b
https://pubmed.ncbi.nlm.nih.gov/32505450
https://pubmed.ncbi.nlm.nih.gov/32505450
Autor:
Hugh D. C. Smyth, Verónica Bucalá, Melina Valeria Mateos, María Verónica Ramírez-Rigo, Nazareth Eliana Ceschan
Publikováno v:
International journal of pharmaceutics. 549(1-2)
The present studies were designed to evaluate inhalatory microparticles carrying indomethacin (IN) for potential local (specific and non-specific bronchial inflammatory asthma responses) and systemic treatments (joint inflammation, rheumatoid arthrit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a4325525f4dcb611ad688a12b612aca
https://pubmed.ncbi.nlm.nih.gov/30071308
https://pubmed.ncbi.nlm.nih.gov/30071308
Publikováno v:
Powder Technology. 285:51-61
Indomethacin (IN) is a non-steroidal antiinflammatory drug. It reduces pain and inflammation in rheumatoid arthritis but its use is associated with high incidence of undesirable gastrointestinal side effects. In addition, its low solubility in water
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2bd90c4abb31848b87db90a8e390ed
https://doi.org/10.1016/j.powtec.2015.02.001
https://doi.org/10.1016/j.powtec.2015.02.001
Publikováno v:
Materials Science and Engineering: C. 41:255-266
The inhalatory route allows drug delivery for local or systemic treatments in a noninvasively way. The current tendency of inhalable systems is oriented to dry powder inhalers due to their advantages in terms of stability and efficiency. In this work
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c76944756ce49be9cd5493094e713b94
https://doi.org/10.1016/j.msec.2014.04.040
https://doi.org/10.1016/j.msec.2014.04.040
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 109
The inhalatory route has emerged as an interesting non-invasive alternative for drug delivery. This allows both pulmonary (local) and systemic treatments (via alveolar absorption). Further advantages in terms of stability, dose and patient preference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e086118b5f27c80f647e38b54493f16
https://pubmed.ncbi.nlm.nih.gov/27697595
https://pubmed.ncbi.nlm.nih.gov/27697595